The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals ...
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...
GlobalData on MSN
FDA to allow one pivotal trial instead of two for drug approval
Prasad and Makary disagree that some may believe this move shows the FDA relaxing its standards.
A trial sponsored by the National Institutes of Health (NIH) is recruiting participants to study a nasal COVID-19 vaccine. The candidate vaccine aims to provide enhanced protection against variants of ...
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
GRAIL's topline results from the NHS-Galleri trial were a clear disappointment with no major implications on ...
World Cancer Day collaboration supports clearer, more inclusive access to cancer clinical trials By hosting the ...
SUCCEED trial enables remote participation for small cell lung cancer patients, addressing location barriers and enhancing research opportunities. NXP800 shows promise in recurrent, platinum-resistant ...
A major challenge in the clinical trial space is ensuring a diverse group of patients enrolls in the program. | A major ...
There is a gap between the evaluation of injury prevention programmes in controlled trials and their use in real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results